Low frequency of Ras gene mutation in spontaneous and gamma-ray-induced thymic lymphomas of scid mice

Radiation Research

Volumn 151, Issue 2, 1999, Pages 142-149

  Nishimura, Mayumi ^a   Wakana, Shigeharu ^b   Kakinuma, Shizuko ^a   Mita, Kazuei ^a   Ishii, Hiroko ^a   Kobayashi, Shigeru ^a   Ogiu, Toshiaki ^a   Sado, Toshihiko ^c   Shimada, Yoshiya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CODON; CONTROLLED STUDY; DNA STRAND BREAKAGE; FEMALE; GAMMA RADIATION; GENE FREQUENCY; GENE MUTATION; IONIZING RADIATION; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; SCID MOUSE; THYMUS LYMPHOMA;

ANIMALS; FEMALE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; LYMPHOMA; MICE; MICE, SCID; MUTATION; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; THYMUS NEOPLASMS;

ANIMALIA;

EID: 0032919306     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579764     Document Type: Article

References (36)

1. K. H. Clifton, Comments on the evidence in support of the epigenetic nature of radiogenic initiation. Mutat. Res. 350, 77-80 (1996).
2. K. Sankaranarayanan and R. Chakraborty, Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. I. Background. Radiat. Res. 143, 121-143 (1995).
3. C. Barlow, S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J. N. Crawley, T. Ried, D. Tagle and A. Wynshaw-Boris, Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86, 159-171 (1996).
4. C. J. Kemp, T. Wheldon and A. Balmain, p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet. 8, 66-69 (1994).
5. A. H. Reitmair, R. Schmits, A. Ewel, B. Bapat, M. Redston, A. Mitri, P. Waterhouse, H. W. Mittrucker, A. Wakeham, B. Liu, A. Thomason, H. Griesser, S. Gallinger, W. G. Ballhausen, R. Fishel and T. W. Mak, MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet. 11, 64-70 (1995).
6. M. J. Bosma and A. M. Carroll, The SCID mouse mutant: Definition, characterization, and potential uses. Annu. Rev. Immunol. 9, 323-350 (1991).
7. G. M. Fulop and R. A. Phillips, The seid mutation in mice causes a general defect in DNA repair. Nature 347, 479-482 (1990).
8. S. Kobayashi, M. Nishimura, Y. Shimada, F. Suzuki, A. Matsuoka, H. Sakamoto, M. Hayashi, T Sofuni, T. Sado and T. Ogiu, Increased sensitivity of seid heterozygous mice to ionizing radiation. Int. J. Radiat. Biol. 72, 537-545 (1997).
9. M. Lieberman, G. A. Hansteen, E. K. Waller, I. L. Weissman and A. Sen-Majumdar, Unexpected effects of the severe combined immunodeficiency mutation on murine lymphomagenesis. J. Exp. Med. 176, 399-405 (1992).
10. I. Guerrero and A. Pellicer, Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutat. Res. 185, 293-308 (1987).
11. M. Okumoto, R. Nishikawa, S. Imai and J. Hilgers. Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. Cancer Res. 50, 3848-3850 (1990).
12. T. Sado, H. Kamisaku and E. Kubo. Bone marrow-thymus interactions during thymic lymphomagenesis induced by fractionated radiation exposure in B10 mice: Analysis using bone marrow transplantation between Thy 1 congenic mice. J. Radiat. Res. 2, 168-180 (1991).
13. M. Muto, E. Kubo, H. Kamisaku and T. Sado, Phenotypic characterization of thymic prelymphoma cells of B10 mice treated with split-dose irradiation. J. Immunol. 144, 849-853 (1990).
14. L. E. Diamond, I. Guerrero and A. Pellicer, Concomitant K-and N-ras gene point mutations in clonal murine lymphoma. Mol. Cell Biol. 8, 2233-2236 (1988).
15. E. W. Newcomb, J. J. Steinberg and A. Pellicer, ras oncogenes and phenotypic staging in N-methylnitrosourea-and γ-irradiation-induced thymic lymphomas in C57BL/6J mice. Cancer Res. 48, 5514-5521 (1988).
16. A. Ootsuyama, H. Makino, M. Nagao, A. Ochiai, Y. Yamauchi and H. Tanooka, Frequent p53 mutation in mouse tumors induced by repeated β-irradiation. Mol. Carcinog. 11, 236-242 (1994).
17. Y. Zhang and G. E. Woloschak, Rb and p53 gene deletions in lung adenocarcinomas from irradiated and control mice. Radiat. Res. 148, 81-89 (1997).
18. P H. Gumerlock, F. J. Meyers, B. A. Foster, T. G. Kawakami and R. W. deVere White, Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: Twelfth codon aspartic acid. Radiat. Res. 117, 198-206 (1989).
19. K. Mita, M. Morimyo, K. Ito. K. Sugaya, K. Ebihara, E. Hongo, T. Higashi, Y. Hirayama and Y. Nakamura, Comprehensive cloning of Schizosaccharomyces pombe genes encoding translation elongation factors. Gene 187, 259-266 (1997).
20. J. R. Maisin, A. Wambersie, G. B. Gerber, J. Gueulette, G. Mattelin and M. Lambiet-Collier, Life shortening and disease incidence in BALB/c mice following a single d(50)-Be neutron or gamma exposure. Radiat. Res. 94, 374-389 (1983).
21. J. R. Maisin, A. Wambersie, G. B. Gerber, G. Mattelin, M. Lambiet-Collier, B. De Coster and J. Gueulette, Life-shortening and disease incidence in C57B1 mice after single and fractionated gamma and high-energy neutron exposure. Radiat. Res. 113, 300-317 (1988).
22. R. L. Ullrich and J. B. Storer, Influence of γ irradiation on the development of neoplastic disease in mice. I. Reticular tissue tumors. Radiat. Res. 80, 303-316 (1979).
23. A. A. Frank, J. M. Collier, C. A. Forsyth, J. A. Oughton and N. I. Kerkvliet, Flow cytometric analysis of thymic lymphosarcoma induced by N-methyl-N-nitrosourea in C57B1/6J mice. Carcinogenesis 13, 509-512 (1992).
24. E. R. Richie, N-Methyl-N-nitrosourea-induced and spontaneous AKR/J thymic lymphomas express distinct differentiation antigen phenotypes. Leuk. Res. 12, 233-242 (1988).
25. - cells for lymphoma development. Cancer Res. 51, 737-740 (1991).
26. S. M. Zhuang, C. Cochran, T. Goodrow, R. W. Wiseman and P. Soderkvist. Genetic alterations of p53 and ras genes in 1,3-butadiene-and 2′,3′-dideoxycytidine-induced lymphomas. Cancer Res. 57, 2710-2714 (1997).
27. H. G. Drexler, R. A. MacLeod, A. Borkhardt and J. W. Janssen, Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 9, 480-500 (1995).
28. L. E. McMorrow, E. W. Newcomb and A. Pellicer, Identification of a specific marker chromosome early in tumor development in gamma-irradiated C57BL/6J mice. Leukemia 2, 115-119 (1988).
29. INK4a alterations in murine primary T-cell lymphomas. Oncogene 14, 1361-1370 (1997).
30. - thymocytes. Proc. Natl. Acad. Sci. USA 93, 4683-4687 (1996).
31. S. R. Sloan, E. W. Newcomb and A. Pellicer, Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation. Mol. Cell Biol. 10, 405-408 (1990).
32. S. Sukumar, B. Armstrong, J. P. Bruyntjes, I. Leav and M. C. Bosland, Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas. Mol. Carcinog. 4, 362-368 (1991).
33. T. Masui, T. Shirai, K. Imaida, M. Hirose, M. Futakuchi, M. Tatematsu and N. Ito, Ki-ras mutations with frequent normal allele loss versus absence of p53 mutations in rat prostate and seminal vesicle carcinomas induced with 3,2′-dimethyl-4-aminobiphenyl. Mol. Carcinog. 13, 21-26 (1995).
34. M. Osaka, S. Matsuo, T. Koh and T. Sugiyama, Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a]anthracene-induced rat leukemia. Mol. Carcinog. 18, 206-212 (1997).
35. S. Takeuchi, C. R. Bartram, C. W. Miller, A. Reiter, T. Seriu, M. Zimmermann, M. Schrappe, N. Mori, J. Slater, I. Miyoshi and H. P. Koeffler, Acute lymphoblastic leukemia of childhood: Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 87, 3368-3374 (1996).
36. A. Baccichet and D. Sinnett, Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukaemia. Br. J. Haematol. 99, 107-114 (1997).